ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 41 filers reported holding ESSA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,999,000 | +59.8% | 422,461 | -10.0% | 0.66% | +109.5% |
| Q3 2021 | $3,755,000 | -79.7% | 469,402 | -27.6% | 0.32% | -74.9% |
| Q2 2021 | $18,522,000 | +35.9% | 648,303 | +38.2% | 1.25% | +19.9% |
| Q1 2021 | $13,631,000 | +192.8% | 469,241 | +20.3% | 1.04% | +153.0% |
| Q4 2020 | $4,655,000 | +169.9% | 390,200 | +56.1% | 0.41% | +142.9% |
| Q3 2020 | $1,725,000 | – | 250,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |